Healthcare-focused private equity firm WindRose Health Investors has acquired CardioOne.

Launched in 2023, CardioOne allows clinicians to focus on delivering high quality patient care while receiving support on the administrative functions within their practices through its technology platform.

“CardioOne’s unique, physician-aligned model meets the market where it is and positions the Company to take advantage of the growing desire among cardiologists to maintain their independence,” says Oliver Moses, a managing partner with WindRose.

McDermott Will & Emery LLP and Bass, Berry & Sims PLC acted as legal advisors to WindRose and Kastner Gravelle LLP acted as legal advisor to CardioOne.